To Evaluate the Immunogenicity and Safety of Two Different Immunization Schedules of Rabies Vaccine (Vero Cell)

Exclusion Criteria

• •First needle exclusion:
• •have allergies, convulsions, seizures, mental and nervous system, such as history, or family history of epilepsy;
• •Allergic to the main ingredient of the investigational vaccine;
• •known to people with poor immune function damage or the tumor, spleen;
• •Axillary temperature \>38.0℃ within 7 days due to acute febrile illness;
• •Patients with axillary body temperature \> 37.0℃;
• •Severe chronic diseases such as congenital malformation, developmental disorder or severe cardiovascular disease, diabetes mellitus, hypertension that cannot be stabilized by drugs, liver and kidney diseases, and malignant tumors;
• •patients with acute and chronic infectious diseases, active infections, severe asthma, infectious skin diseases;
• •pregnant and lactating women; Any circumstances that the investigator believes may affect the assessment of the trial.
• •Subsequent needle exclusions:
• •any serious adverse event causally related to vaccination;
• •the researchers think that may affect test evaluation of any situation.